Houman Dehghani, PhD Amgen

Dr. Dehghani is a Senior Director at Allogene Therapeutics. His area of expertise is adventitious agent safety and process development for cell therapies and biologics. Following his post-doctoral training at the National Institute of Allergy and Infectious Diseases, he joined Amgen, Inc. in 2003 and Allogene Therapeutics in 2018.  
Currently, he leads early process development and adventitious agent safety groups at Allogene Therapeutics. 

Houman holds a Ph.D. degree from Michigan State University in Cell and Molecular Biology.